|
These pictures belong to hemangiosarcoma patient Ilhan K. whom Dr. Gorgun treated at the Ankara Numune Hospital as part of a preliminiary clinical trial made with GEMM Therapy.
The following is excerpt is from the voice recordings in a seminar held at the Ankara University by the Head Physician of the Ankara Numune Hospital Dr. Turhan Temucin and the Head Physician of the Ankara Oncology Hospital Dr. Haluk Nurbaki concerning the outcomes of the trial. For over an hour they were describing the effects of electromagnetic treatment on patients to their fellow doctors:
“The hemangisarcoma patient was considered a terminal case by the clinic headed by Dr. Mustafa Sinav. The tumor was inoperable and he had no option but amputation. Although it might be possible to stop bleeding with radiotherapy we were not able to stop its bleeding even with high dose and the patient was given 2 units of blood per day. While he was scheduled for amputation he was considered eligible for this new therapy. In his left leg he had a tumor in the size of the head of a child that was continuously bleeding causing anemia and debility. With the protocol number 568/809 he was handed to the team for 8‐9 days of treatment.
Following the first treatment on November 12, the bleeding of the patient completely seized. Afterwards with follow up treatment the mass was downsized to an orange. And as the tumor mass became operable, it was removed by a surgical team headed by Dr. Yılmaz Kadioglu.”
In the pictures on the right you can see the condition of the inoperable massive tumor prior GEMM Therapy, and afterwards the conditions of the patient once the tumor was successfully removed following the electromagnetic ATP depletion therapy. |